Details

Industries

Biotechnology,Health Care,Health Diagnostics,Pharmaceutical

Founded date

Jan 1, 1999

Number Of Employee

11 - 50

Operating Status

Active

Isconova AB is an R&D company that develops and commercializes adjuvants and vaccines. It provides its adjuvants for veterinary and human vaccines for an enhanced immune reaction with longer duration. The products of the company includes Matrix-M, which is a cell-mediated and an antibody mediated immune response for use in vaccines for humans, dogs, and cats. Matrix-C vaccines are used for horses and Matrix-Q vaccines are used for cows and fishes. Matrix-F is also used for fishes. It also offers AbISCO research reagents, including AbISCO-100 for use in saponin sensitive animal species, such as mice.

Isconova AB is a Sweden-based company that was founded in 1999. The company was acquired by Novavax AB on June, 2013.